Drug Warning: Mobic
Generic name: meloxicam (class of drugs known as NSAIDs)
Manufactured and marketed by: Abbott Laboratories
Purpose: Prescribed to patients suffering from the symptoms of rheumatoid arthritis and osteoarthritis, which may include swelling, inflammation, stiffness, and joint pain.
Side Effects Reported
- NSAIDs have been linked to liver damage.
- Patients taking NSAIDs, including Mobic, should be aware of the symptoms of liver damage which include yellow coloring of the skin or eyes, dark urine, fatigue, nausea, vomiting, loss of appetite, and flu like symptoms.
NSAIDs may also be linked to cardiovascular problems including heart attack and stroke. In addition, NSAIDs may be associated with an increased risk of hypertension, congestive heart failure, and edema. NSAIDs as a class are also linked to gastrointestinal problems including bleeding and ulceration.
Seeger Weiss is not currently pursuing lawsuits on this drug, but its drug warnings will remain on our radar.Free Case Evaluation
A California judge has ruled that Essure lawsuits filed by women who claim serious injury caused by the permanent birth control device, will be allowed to advance despite the manufacture’s claim of [...]August 16, 2016 By: Seeger Weiss read more
On the heels of what could be the largest class action settlement in US history regarding the Volkswagen emission scandal, Mercedes-Benz US and its parent company, German automaker Daimler, are now under [...]July 1, 2016 By: Seeger Weiss read more
June 28, 2016–A proposed settlement of the Volkswagen “Clean Diesel” Marketing, Sales Practices, and Products Liability Litigation has been filed in the Northern District of California, where the federal multidistrict litigation is [...]June 29, 2016 By: Seeger Weiss read more